Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
European Journal of Cancer (Oxford, England : 1990)|April 26, 2022
The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasmsIvan Borbath, Rocio Garcia-Carbonero, Damir Bikmukhametov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009
Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study GroupAnja Rinke, Hans-Helge Müller, Carmen Schade-Brittinger, et al.
The Oncologist|February 25, 2017
Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical OutcomeFrancesco Panzuto, Elettra Merola, Marianne Ellen Pavel, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 27, 2018
Experience with teduglutide treatment for short bowel syndrome in clinical practiceSophie Pevny, Sebastian Maasberg, Anja Rieger, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 14, 2009
Results after balloon angioplasty or stenting of atherosclerotic subclavian artery obstructionSebastian Sixt, Aljoscha Rastan, Uwe Schwarzwälder, et al.
Oncology Research and Treatment|February 23, 2023
High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany StudyFrancis Maren Konermann, Nele Gessler, Peter Wohlmuth, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|November 23, 2016
Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel SyndromeKishore R Iyer, Marek Kunecki, Joseph I Boullata, et al.
Pageof 12